V012-5573 Screening compound: N-[(3-fluorophenyl)methyl]-3-methoxy-N-(4-{[(propan-2-yl)carbamoyl]methyl}phenyl)benzamide

V012-5573 Screening compound: N-[(3-fluorophenyl)methyl]-3-methoxy-N-(4-{[(propan-2-yl)carbamoyl]methyl}phenyl)benzamide
V012-5573 Screening compound: N-[(3-fluorophenyl)methyl]-3-methoxy-N-(4-{[(propan-2-yl)carbamoyl]methyl}phenyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-5573
N-[(3-fluorophenyl)methyl]-3-methoxy-N-(4-{[(propan-2-yl)carbamoyl]methyl}phenyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-5573

Molecular Formula

C26H27FN2O3 (C26 H27 FN2 O3)

Compound Name

N-[(3-fluorophenyl)methyl]-3-methoxy-N-(4-{[(propan-2-yl)carbamoyl]methyl}phenyl)benzamide

IUPAC name

N-[(3-fluorophenyl)methyl]-3-methoxy-N-(4-{[(propan-2-yl)carbamoyl]methyl}phenyl)benzamide

SMILES

CC(C)NC(Cc(cc1)ccc1N(Cc1cccc(F)c1)C(c1cc(OC)ccc1)=O)=O

InChI

InChI=1S/C26H27FN2O3/c1-18(2)28-25(30)15-19-10-12-23(13-11-19)29(17-20-6-4-8-22(27)14-20)26(31)21-7-5-9-24(16-21)32-3/h4-14,16,18H,15,17H2,1-3H3,(H,28,30)

InChI Key

AXTRXAUNONFHHQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19903176

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

434.51

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.344

Distribution Coefficient, logD

4.344

Water Solubility, LogSw

-4.47

Polar Surface Area

46.579

Acid Dissociation Constant (pKa)

14.92

Base Dissociation Constant (pKb)

1.16

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.10

V012-5573 in Drug Discovery

Included in Screening Libraries

Glucocorticoid receptors Library (4806 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
Targets:
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V012-5573 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-5573?
Check Price and Availability of V012-5573, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-5573 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-5573
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-5573
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-5573 available by request